Xiao Hui Ji
Director/Miembro de la Junta en LEGEND BIOTECH CORPORATION .
Fortuna: 299 807 $ al 31/12/2024
Perfil
Xiao Hui Ji is the Chairman & Chief Executive Officer of Elpiscience Biopharma Ltd.
and Elpiscience Biopharmaceuticals, Inc., both founded in 2017.
He was also the Chief Executive Officer of PharmaLegacy Laboratories (Shanghai) Co., Ltd., founded in 2008.
Dr. Ji is currently an Independent Director at Legend Biotech Corp.
since 2020.
Previously, he held the position of Director at The BayHelix Group from 2008 to 2013, Vice President-Business Development at Roche Holding AG from 2013 to 2016, and Partner at LAV Management Co., Ltd.
from 2017 to 2020.
Dr. Ji holds an MBA from The University of Chicago, a doctorate from The University of Sheffield, and a doctorate from China Medical University.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
LEGEND BIOTECH CORP.
0,01 % | 31/12/2023 | 18 427 ( 0,01 % ) | 299 807 $ | 31/12/2024 |
Cargos activos de Xiao Hui Ji
Empresas | Cargo | Inicio |
---|---|---|
LEGEND BIOTECH CORPORATION | Director/Miembro de la Junta | 01/05/2020 |
Elpiscience Biopharma Ltd.
![]() Elpiscience Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Elpiscience Biopharma Ltd. engages in the development of cutting-edge immunotherapies to fight cancer. Its business scope includes technology research and development, transfer of own technology achievements and provision of related technical advice and technical services of biomedicine and biotechnology; import and export, and wholesale of mechanical equipment, electronic products, instrumentation, and plastic products. The company was founded on September 30, 2017 and is headquartered in Shanghai, China. | Director Ejecutivo | 01/06/2017 |
Elpiscience Biopharmaceuticals, Inc.
![]() Elpiscience Biopharmaceuticals, Inc. BiotechnologyHealth Technology Elpiscience Biopharmaceuticals, Inc. is an investment holding company, which engages in the research and development of immuno-oncology therapies. It focuses on the development of clinical-stage drug candidates namely, ES102, ES014, ES104, and ES009. The company was founded by Xiao Hui Ji and Hong Tao Lu in June 2017 and is headquartered in Shanghai, China. | Director Ejecutivo | 01/06/2017 |
Antiguos cargos conocidos de Xiao Hui Ji.
Empresas | Cargo | Fin |
---|---|---|
LAV Management Co., Ltd.
![]() LAV Management Co., Ltd. Investment ManagersFinance LAV Management Co., Ltd. (LAV) is a venture capital subsidiary of Eli Lilly & Co. founded in 2008. The firm is headquartered in Shanghai, China with branches located in Central, Hong Kong and United States. | Corporate Officer/Principal | 01/05/2020 |
ROCHE HOLDING AG | Corporate Officer/Principal | 01/12/2016 |
The BayHelix Group | Director/Miembro de la Junta | 01/01/2013 |
PharmaLegacy Laboratories (Shanghai) Co., Ltd.
![]() PharmaLegacy Laboratories (Shanghai) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services PharmaLegacy Laboratories (Shanghai) Co., Ltd. engages in the provision of pharmacodynamics, pharmacokinetics, non-GLP toxicology, in vitro immunology, and three types of medical device evaluation services in line with international standards. It provides drug research & development preclinical research services such as pharmacodynamic research evaluation and pharmacokinetic research evaluation; device research & development preclinical research services such as preclinical effectiveness and safety evaluation of innovative medical devices; and experimental mice. The company was founded on March 7, 2008 and is headquartered in Shanghai, China. | Director Ejecutivo | 01/01/2012 |
Formación de Xiao Hui Ji.
China Medical University | Doctorate Degree |
The University of Sheffield | Doctorate Degree |
The University of Chicago | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
LEGEND BIOTECH CORPORATION | Health Technology |
ROCHE HOLDING AG | Health Technology |
Empresas privadas | 5 |
---|---|
Elpiscience Biopharma Ltd.
![]() Elpiscience Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Elpiscience Biopharma Ltd. engages in the development of cutting-edge immunotherapies to fight cancer. Its business scope includes technology research and development, transfer of own technology achievements and provision of related technical advice and technical services of biomedicine and biotechnology; import and export, and wholesale of mechanical equipment, electronic products, instrumentation, and plastic products. The company was founded on September 30, 2017 and is headquartered in Shanghai, China. | Health Technology |
LAV Management Co., Ltd.
![]() LAV Management Co., Ltd. Investment ManagersFinance LAV Management Co., Ltd. (LAV) is a venture capital subsidiary of Eli Lilly & Co. founded in 2008. The firm is headquartered in Shanghai, China with branches located in Central, Hong Kong and United States. | Finance |
The BayHelix Group | |
PharmaLegacy Laboratories (Shanghai) Co., Ltd.
![]() PharmaLegacy Laboratories (Shanghai) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services PharmaLegacy Laboratories (Shanghai) Co., Ltd. engages in the provision of pharmacodynamics, pharmacokinetics, non-GLP toxicology, in vitro immunology, and three types of medical device evaluation services in line with international standards. It provides drug research & development preclinical research services such as pharmacodynamic research evaluation and pharmacokinetic research evaluation; device research & development preclinical research services such as preclinical effectiveness and safety evaluation of innovative medical devices; and experimental mice. The company was founded on March 7, 2008 and is headquartered in Shanghai, China. | Commercial Services |
Elpiscience Biopharmaceuticals, Inc.
![]() Elpiscience Biopharmaceuticals, Inc. BiotechnologyHealth Technology Elpiscience Biopharmaceuticals, Inc. is an investment holding company, which engages in the research and development of immuno-oncology therapies. It focuses on the development of clinical-stage drug candidates namely, ES102, ES014, ES104, and ES009. The company was founded by Xiao Hui Ji and Hong Tao Lu in June 2017 and is headquartered in Shanghai, China. | Health Technology |
- Bolsa de valores
- Insiders
- Xiao Hui Ji